COVID-19: Serum Institute`s Covishield, Bharat Biotech`s Covaxin get approval for restricted use in India

DGCI on Sunday (January 3) formally approved Serum Institute's Covishield and Bharat Biotech's Covaxin for use in India. 

https://ift.tt/eA8V8J DGCI on Sunday (January 3) formally approved Serum Institute's Covishield and Bharat Biotech's Covaxin for use in India.  from Zee News :India National https://ift.tt/2Ld5ngA